论文部分内容阅读
来自于日本东京医科齿科大学的研究人员最新研究发现,“W9肽”可抑制破骨细胞的生成,有望用于开发治疗骨质疏松症的药物。“W9肽”是由9个氨基酸结合而成的;在与破
The latest research by researchers from Tokyo Medical and Dental University in Japan found that “W9 peptide” can inhibit osteoclastogenesis and is expected to be used to develop drugs for the treatment of osteoporosis. The “W9 peptide” is a combination of 9 amino acids; broken with